These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses. Rivers JK, McLean DI. Arch Dermatol; 1997 Oct; 133(10):1239-42. PubMed ID: 9382562 [Abstract] [Full Text] [Related]
4. Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze). Nelson C, Rigel D, Smith S, Swanson N, Wolf J. J Drugs Dermatol; 2004 Oct; 3(4):401-7. PubMed ID: 15303784 [Abstract] [Full Text] [Related]
5. Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results. Stockfleth E, Kerl H, Zwingers T, Willers C. Br J Dermatol; 2011 Nov; 165(5):1101-8. PubMed ID: 21517801 [Abstract] [Full Text] [Related]
13. Diclofenac sodium 3% gel in the treatment of actinic keratoses postcryosurgery. Berlin JM, Rigel DS. J Drugs Dermatol; 2008 Jul; 7(7):669-73. PubMed ID: 18664159 [Abstract] [Full Text] [Related]
16. Treatment of multiple actinic keratoses with topical diclofenac 3% gel in organ transplant recipients: a series of six cases. Ulrich C, Hackethal M, Ulrich M, Howorka A, Forschner T, Sterry W, Stockfleth E. Br J Dermatol; 2007 May; 156 Suppl 3():40-2. PubMed ID: 17488405 [Abstract] [Full Text] [Related]
17. Topical 3% diclofenac in 2.5% hyaluronic acid gel: a review of its use in patients with actinic keratoses. Jarvis B, Figgitt DP. Am J Clin Dermatol; 2003 May; 4(3):203-13. PubMed ID: 12627996 [Abstract] [Full Text] [Related]